Skip to main content
Erschienen in: Journal of Gastroenterology 8/2010

01.08.2010 | Original Article—Liver, Pancreas, and Biliary Tract

Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease

verfasst von: Teruki Miyake, Sheikh Mohammad Fazle Akbar, Osamu Yoshida, Shiyi Chen, Yoichi Hiasa, Bunzo Matsuura, Masanori Abe, Morikazu Onji

Erschienen in: Journal of Gastroenterology | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Background/aims

The magnitude of antigen-specific immunity was assessed in a murine model of nonalcoholic fatty liver diseases (NAFLD). Because antigen-specific immunity was diminished in NAFLD mice, the underlying mechanisms were evaluated through analysis of the functions of antigen-presenting dendritic cells (DC) and other immunocytes.

Methods

For 12 weeks, NAFLD mice received a high-fat (60%) and high-calorie (520 kcal/100 g) diet. C57BL/6 mice (controls) received a standard diet. NAFLD mice and control mice were immunized with hepatitis B vaccine containing hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg). Antibody to HBsAg (anti-HBs), HBsAg and HBcAg-specific cellular immune response and functions of whole spleen cells, T lymphocytes, B lymphocytes and spleen DCs of NAFLD and control mice were assessed in vitro.

Results

Levels of anti-HBs and the magnitude of proliferation of HBsAg and HBcAg-specific lymphocytes were significantly lower in NAFLD mice than control mice (P < 0.05). The spleen cells of NAFLD mice produced significantly higher levels of inflammatory cytokines (P < 0.05) and exhibited significantly increased T cell proliferation compared with control mice (P < 0.05). However, the antigen processing and presenting capacities of spleen DCs were significantly decreased in NAFLD mice compared with control mice (P < 0.05). Palmitic acid, a saturated fatty acid, caused diminished antigen processing and presenting capacity of both murine and human DCs.

Conclusions

Nonalcoholic fatty liver disease mice exhibit decreased magnitudes of antigen-specific humoral and cellular immune responses. This effect is mainly, if not solely, due to impaired antigen processing and presentation capacities of DC.
Literatur
2.
Zurück zum Zitat Tordjman J, Guerre-Millo M, Clément K. Adipose tissue inflammation and liver pathology in human obesity. Diabetes Metab. 2008;34:658–63.CrossRefPubMed Tordjman J, Guerre-Millo M, Clément K. Adipose tissue inflammation and liver pathology in human obesity. Diabetes Metab. 2008;34:658–63.CrossRefPubMed
3.
Zurück zum Zitat Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.CrossRefPubMed Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.CrossRefPubMed
4.
5.
6.
Zurück zum Zitat Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology. 2005;42:880–5.CrossRefPubMed Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology. 2005;42:880–5.CrossRefPubMed
7.
Zurück zum Zitat Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–80.CrossRefPubMed Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–80.CrossRefPubMed
8.
Zurück zum Zitat Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T. Role of liver-infiltrating CD3+ CD56+ natural killer T cells in the patogénesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2009;21:673–80.CrossRefPubMed Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T. Role of liver-infiltrating CD3+ CD56+ natural killer T cells in the patogénesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2009;21:673–80.CrossRefPubMed
9.
Zurück zum Zitat Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R, Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology. 2007;46:1519–29.CrossRefPubMed Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R, Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology. 2007;46:1519–29.CrossRefPubMed
10.
Zurück zum Zitat Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol. 2002;282:G1–5.PubMed Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol. 2002;282:G1–5.PubMed
11.
Zurück zum Zitat Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8(+) effector T cells contribute to macrophage requirement and adipose tissue inflammation in obesity. Nat Med. 2009;15:846–7.CrossRef Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8(+) effector T cells contribute to macrophage requirement and adipose tissue inflammation in obesity. Nat Med. 2009;15:846–7.CrossRef
12.
Zurück zum Zitat Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006;39:137–41.CrossRefPubMed Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006;39:137–41.CrossRefPubMed
13.
Zurück zum Zitat Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med. 1986;314:1393.PubMed Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med. 1986;314:1393.PubMed
14.
Zurück zum Zitat Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol. 2003;98:2064–71.CrossRefPubMed Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol. 2003;98:2064–71.CrossRefPubMed
15.
Zurück zum Zitat Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007;27:607–11.CrossRefPubMed Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007;27:607–11.CrossRefPubMed
16.
Zurück zum Zitat Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis. 2007;27:152–60.CrossRefPubMed Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis. 2007;27:152–60.CrossRefPubMed
17.
18.
Zurück zum Zitat Onji M, Akbar SM. Dendritic cells in clinics. 2nd ed. Tokyo: Springer; 2008. Onji M, Akbar SM. Dendritic cells in clinics. 2nd ed. Tokyo: Springer; 2008.
19.
Zurück zum Zitat Fazle Akbar SM, Abe M, Yoshida O, Murakami H, Onji M. Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes. Curr Med Chem. 2006;13:3113–9.CrossRefPubMed Fazle Akbar SM, Abe M, Yoshida O, Murakami H, Onji M. Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes. Curr Med Chem. 2006;13:3113–9.CrossRefPubMed
20.
Zurück zum Zitat Niiya T, Akbar SM, Yoshida O, Miyake T, Matsuura B, Murakami H, et al. Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice. J Nutr. 2007;137:671–5.PubMed Niiya T, Akbar SM, Yoshida O, Miyake T, Matsuura B, Murakami H, et al. Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice. J Nutr. 2007;137:671–5.PubMed
21.
Zurück zum Zitat Akbar SM, Onji M, Inaba K, Yamamura K-I, Ohta Y. Low responsiveness of hepatitis B virus transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen presenting activity of dendritic cells. Immunology. 1993;78:468–73.PubMed Akbar SM, Onji M, Inaba K, Yamamura K-I, Ohta Y. Low responsiveness of hepatitis B virus transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen presenting activity of dendritic cells. Immunology. 1993;78:468–73.PubMed
22.
Zurück zum Zitat Akbar SM, Inaba K, Onji M. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by g-interferon: abrogation of immune response defect to a T-cell-dependent antigen. Immunology. 1996;87:519–27.CrossRefPubMed Akbar SM, Inaba K, Onji M. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by g-interferon: abrogation of immune response defect to a T-cell-dependent antigen. Immunology. 1996;87:519–27.CrossRefPubMed
23.
Zurück zum Zitat Akbar SM, Abe M, Masumoto T, Horiike N, Onji M. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol. 1999;30:755–64.CrossRefPubMed Akbar SM, Abe M, Masumoto T, Horiike N, Onji M. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol. 1999;30:755–64.CrossRefPubMed
24.
Zurück zum Zitat Akbar SM, Furukawa S, Yoshida O, Hiasa Y, Horiike N, Onji M. Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells. J Hepatol. 2007;47:60–6.CrossRef Akbar SM, Furukawa S, Yoshida O, Hiasa Y, Horiike N, Onji M. Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells. J Hepatol. 2007;47:60–6.CrossRef
25.
Zurück zum Zitat Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, Neumeier M, et al. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology. 2009;126:233–45.CrossRefPubMed Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, Neumeier M, et al. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology. 2009;126:233–45.CrossRefPubMed
26.
Zurück zum Zitat Håversen L, Danielsson KN, Fogelstrand L, Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis. 2009;202:382–93.CrossRefPubMed Håversen L, Danielsson KN, Fogelstrand L, Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis. 2009;202:382–93.CrossRefPubMed
27.
Zurück zum Zitat Yoshida O, Akbar F, Miyake T, Abe M, Matsuura B, Hiasa Y, et al. Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell. Clin Exp Immunol. 2008;152:174–81.CrossRefPubMed Yoshida O, Akbar F, Miyake T, Abe M, Matsuura B, Hiasa Y, et al. Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell. Clin Exp Immunol. 2008;152:174–81.CrossRefPubMed
28.
Zurück zum Zitat Coll T, Eyre E, Rodriguez-Calvo R, Palomer X, Sanchez RM, Merols M, et al. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle. J Biol Chem. 2008;283:11107–16.CrossRefPubMed Coll T, Eyre E, Rodriguez-Calvo R, Palomer X, Sanchez RM, Merols M, et al. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle. J Biol Chem. 2008;283:11107–16.CrossRefPubMed
29.
Zurück zum Zitat Guaraldi G, Squillace N, Stentarelli C, Orlando G, D’Amico R, Ligabue G, et al. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Clin Infect Dis. 2008;47:250–7.CrossRefPubMed Guaraldi G, Squillace N, Stentarelli C, Orlando G, D’Amico R, Ligabue G, et al. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Clin Infect Dis. 2008;47:250–7.CrossRefPubMed
30.
Zurück zum Zitat Hill-Baskin AE, Markiewski MM, Buchner DA, Shao H, DeSantis D, Hsiao G, et al. Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum Mol Genet. 2009;18:2975–88.CrossRefPubMed Hill-Baskin AE, Markiewski MM, Buchner DA, Shao H, DeSantis D, Hsiao G, et al. Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum Mol Genet. 2009;18:2975–88.CrossRefPubMed
31.
Zurück zum Zitat Abe M, Akbar SM, Horiike N, Onji M. Inability of liver dendritic cells from mouse with experimental hepatitis to process and present specific antigens. Hepatol Res. 2003;26:61–7.CrossRefPubMed Abe M, Akbar SM, Horiike N, Onji M. Inability of liver dendritic cells from mouse with experimental hepatitis to process and present specific antigens. Hepatol Res. 2003;26:61–7.CrossRefPubMed
32.
Zurück zum Zitat Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41:1241–8.CrossRefPubMed Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41:1241–8.CrossRefPubMed
Metadaten
Titel
Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease
verfasst von
Teruki Miyake
Sheikh Mohammad Fazle Akbar
Osamu Yoshida
Shiyi Chen
Yoichi Hiasa
Bunzo Matsuura
Masanori Abe
Morikazu Onji
Publikationsdatum
01.08.2010
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 8/2010
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0218-4

Weitere Artikel der Ausgabe 8/2010

Journal of Gastroenterology 8/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.